Detection of southern African human immunodeficiency virus type 1 subtypes by polymerase chain reaction: evaluation of different primer pairs and conditions. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Detection of southern African human immunodeficiency virus type 1 subtypes by polymerase chain reaction: evaluation of different primer pairs and conditions.

J Virol Methods. 1995 Nov;55(3):391-400. Unique Identifier : AIDSLINE MED/96187329
Engelbrecht S; van Rensburg EJ; Department of Medical Virology, University of Stellenbosch,; Tygerberg, South Africa.


Abstract: The purpose of the study was to develop a specific and sensitive PCR protocol using env, gag and LTR primer pairs to detect HIV-1 subtypes present in the Western Cape, South Africa. Twenty-two virus strains, belonging to HIV-1 subtypes B, C and D, were randomly selected for PCR evaluation. Cell lysates prepared from these virus-infected cultured cells were tested using 5 different primer pairs: gag SK38/SK39; gag 22/SK39; gag a/b, gag c/d (nested); env SK68/SK69 and LTR SK29/SK30. Eight different PCR profiles were evaluated: one profile each for the 3 gag primer pairs, 3 profiles for the env and 2 profiles for the LTR primer pairs. The number of PCR cycles, time per cycle and/or annealing temperature were changed in each profile. The optimum PCR profile for a specific primer pair was defined as that which detected one copy of proviral plasmid DNA after dot-blot hybridisation. Gag primer pairs detected HIV-1 DNA in all 22 samples. With the env primer pair, suboptimal conditions failed to detect most of the HIV-1 subtype C samples. By increasing the number of cycles and time per cycle, a 100% sensitivity was achieved. With the LTR primer pair all samples were detected by decreasing the annealing temperature and increasing the individual cycle times. This confirms that once PCR conditions are optimised, all HIV-1 subtypes in our study could be detected using different PCR primer pairs.
Keywords: Acquired Immunodeficiency Syndrome/VIROLOGY AIDS-Related Complex/VIROLOGY Base Sequence DNA Primers DNA, Viral/GENETICS Evaluation Studies Genes, env/*GENETICS Genes, gag/GENETICS Human HIV-1/CLASSIFICATION/GENETICS/*ISOLATION & PURIF Molecular Sequence Data Polymerase Chain Reaction/*METHODS Reproducibility of Results Retrospective Studies Sensitivity and Specificity South Africa Support, Non-U.S. Gov't Temperature JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/virologyaids-relatedcomplex/virologybasesequencednaprimersdna,viral/geneticsevaluationstudiesgenes,env/KWDgeneticsgenes,gag/geneticshumanhiv-1/classification/genetics/KWDisolation&purifmolecularsequencedatapolymerasechainreaction/KWDmethodsreproducibilityofresultsretrospectivestudiessensitivityandspecificitysouthafricasupport,non-uKWDsKWDgov'ttemperaturejournalarticle
960830
M9681191

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .